MiR-30a-5p inhibits osteosarcoma cell proliferation and migration by targeting FOXD1

被引:45
|
作者
Tao, Jun [1 ]
Cong, Haibo [2 ]
Wang, Hongyan [2 ]
Zhang, Daoqiang [2 ]
Liu, Chuanjie [2 ]
Chu, Hongxia [2 ]
Qing, Qianfeng [2 ]
Wang, Kunzheng [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthoped, Xian 710004, Shaanxi, Peoples R China
[2] Weihai Cent Hosp, Weihai City Key Lab Autoimmun, Weihai 264400, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Osteosarcoma; FOXD1; miR-30a-5p; Cell proliferation; Cell migration; BREAST-CANCER; GROWTH; SUPPRESSES; APOPTOSIS; MICRORNAS; PROGNOSIS; GENETICS; STAND;
D O I
10.1016/j.bbrc.2018.06.121
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite a number of studies have emphasized the extensive role of microRNA (miRNA) in the development of multiple cancers, the role of miR-30a-5p in the progression of osteosarcoma (OS) and the underlying mechanism are still limited. We detected the expression level of MiR-30a-5p and forkhead box D1 (FOXD1) in Clinical OS specimens and found that miR-30a-5p was significantly decreased while FOXD1 was markedly increased. Dual luciferase assay confirmed that FOXD1 was directly regulated by miR-30a-5p. In vitro assay showed that inhibitior of FOXD1 suppressed cell proliferation, migration and invasion in MG63 and U2OS cells, while overexpression of FOXD1 promoted OS cell proliferation and migration. In vivo assay further showed the inhibition of tumor growth after knockdown of FOXD1. These results suggested that FOXD1 might play key roles in OS development and progression, and was negatively regulated by miR-30a-5p in OS. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:1092 / 1097
页数:6
相关论文
共 50 条
  • [21] Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer
    Sun, Yi
    Yang, Bin
    Lin, Maosong
    Yu, Hong
    Chen, Hui
    Zhang, Zhenyu
    CANCER BIOMARKERS, 2019, 24 (03) : 299 - 305
  • [22] MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR
    Liu, Yang
    Zhu, Shu-Tao
    Wang, Xiao
    Deng, Jun
    Li, Wei-Hua
    Zhang, Peng
    Liu, Bing-Shan
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2016, 15 (05) : NP40 - NP48
  • [23] MiR-9-5p Inhibits the Proliferation, Migration and Invasion of Choroidal Melanoma by Targeting BRAF
    Ying, Manman
    Feng, Hao
    Zhang, Xiaonan
    Liu, Ran
    Ning, Hong
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [24] miR-30a-5p inhibits osteogenesis and promotes periodontitis by targeting Runx2
    Liu, Xiangdong
    Yang, Bo
    Zhang, Yan
    Guo, Xiaorui
    Yang, Qianjuan
    Liu, Xiaojing
    Bai, Qingxia
    Lu, Qun
    BMC ORAL HEALTH, 2021, 21 (01)
  • [25] MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3
    Huang, Na
    Lin, Jing
    Ruan, Jian
    Su, Ning
    Qing, Ruzhai
    Liu, Feiye
    He, Benfu
    Lv, Chengwei
    Zheng, Dayong
    Luo, Rongcheng
    FEBS LETTERS, 2012, 586 (06) : 884 - 891
  • [26] miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1
    Wang, Xuesong
    Peng, Lei
    Gong, Xiaojin
    Zhang, Xiugong
    Sun, Ruifu
    Du, Jinlong
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 50 (06) : 2249 - 2259
  • [27] MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells
    Ruan, Wen-Dong
    Wang, Pei
    Feng, Shiqing
    Xue, Yuan
    Zhang, Bin
    ONCOTARGETS AND THERAPY, 2016, 9 : 303 - 313
  • [28] Chinese Herb Resveratrol Inhibits Renal Pelvic Cancer Cell Proliferation via Regulating miR-30a-5p
    Zhu, Zunwei
    Wu, Jinggong
    Xu, Lieyu
    Wan, Yong
    Chao, Haichao
    Sun, Ting
    JOURNAL OF BIOBASED MATERIALS AND BIOENERGY, 2021, 15 (02) : 253 - 259
  • [29] miR-877 inhibits the proliferation, migration, and invasion of osteosarcoma cells by targeting gamma-glutamylcyclotransferase
    Jia, Chenguang
    Gao, Jianguo
    Wang, Lianbo
    Li, Zhuo
    Dong, Zhaoliang
    Yao, Liming
    Yao, Xiaowei
    ENDOCRINE JOURNAL, 2021, 68 (09) : 1109 - 1116
  • [30] FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27
    Zhao, Yi-Fan
    Zhao, Jing-Yu
    Yue, Hong
    Hu, Ke-Shi
    Shen, Hao
    Guo, Zheng-Gang
    Su, Xiao-Jun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 456 (01) : 232 - 237